ROSEN, A LEADING NATIONAL FIRM, Encourages Spectrum Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – SPPI
01. September 2021 15:56 ET
|
The Rosen Law Firm PA
NEW YORK, Sept. 01, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of...
The Biosimilars Market will hit $69 billion by 2025: Global Market Insights, Inc.
22. Mai 2019 05:30 ET
|
Global Market Insights, Inc
Selbyville, Delaware, May 22, 2019 (GLOBE NEWSWIRE) -- Recombinant glycosylated proteins segment of biosimilars market is estimated to grow at around 28.7% over the estimation period. Increase in...